Article
U.S. FDA puts partial hold on Blueprint Medicines' cancer drug trial
Rating:
0.0
Views:
56
Likes:
1
Library:
1
Blueprint Medicines Corp said on Friday the U.S. drug regulator had put on partial hold an early-stage trial testing its experimental cancer drug due to safety concerns, sending its shares down nearly 6%.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value